CD8A and HIV-1 infection: We hypothesize that these levels might constitute a response to the cART received or a result of larger active CD4 + and CD8 + T cell populations in the patients as cART initiation was delayed, given that the immune system in these patients would need to activate a larger pool of T cells to combat HIV-1 infection than in those starting cART very early44.